Dr. C. Scart has more than 25 years of in-depth experience in the development and life-cycle management of innovative medicinal products in multinational pharmaceutical companies such as Janssen Cilag, Glaxo Wellcome, Recordati, and CSLBehring as a Clinical Development physician and Medical Director. Thereafter,she joined small biotechs (Pharnext as CMO, and Bioprojet as Head of Clinical Development) leading multi-national clinical development programs from Phase I to Phase IV across a broad range of therapeutic areas (mainly in neurology and rare diseases) and providing support for regulatory filings and interactions with FDA, EMA, and national regulatory authorities.

Her professional education as a Medical Doctor certified in Pediatrics also includes postgraduate Master’s degrees in Public Health (Pierre et Marie Curie Paris VI Medicine University), and in the Methodology of therapeutic evaluation (Lariboisière Paris VII Medicine University).